MYRIAD GENETICS INC — Director's Dealing 2015

Sep 17, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2015-09-15

Reporting Person: LANCHBURY JERRY S (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-09-15	Common Stock	M	50000.0	$16.53	Acquired	127634	Direct
2015-09-15	Common Stock	S	50000.0	$39.8791	Disposed	77634	Direct
2015-09-15	Common Stock	M	10000.0	$18.06	Acquired	87634	Direct
2015-09-15	Common Stock	S	10000.0	$39.8791	Disposed	77634	Direct
2015-09-17	Common Stock	F	6897.0	$41.39	Disposed	70737	Direct
2015-09-17	Common Stock	M	270.0	$16.53	Acquired	71007	Direct
2015-09-17	Common Stock	S	270.0	$41.39	Disposed	70737	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-09-15	Non-Qualified Stock Option (right to buy)	$16.53	M	50000.0	Disposed	2020-09-15	Common Stock (50000)	Direct
2015-09-17	Non-Qualified Stock Option (right to buy)	$16.53	M	270.0	Disposed	2020-09-15	Common Stock (270)	Direct
2015-09-15	Non-Qualified Stock Option (right to buy)	$18.06	M	10000.0	Disposed	2017-09-26	Common Stock (10000)	Direct

Footnotes

F1: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person.

F2: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.